Sector Gamma AS
- SEC CIK
- 0001475373
- 最新申報
- 2026/8/12
2023 年第 4 季持倉
持倉截至 2023/12/31，2024/2/5 申報。只含多頭部位，變化是跟 2023 年第 3 季比股數。
- 持股檔數
- 30
- 較 2023 年第 3 季 +2
- 總值
- $4.12 億
- 較 2023 年第 3 季 +$2,086 萬 (+5.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MDTMedtronic plc | Stock | 435,075 | $3,584 萬 | 8.7% | +107,172+32.7% | 加碼 | 歷史 |
| PFEPfizer Inc | Stock | 1,093,416 | $3,148 萬 | 7.6% | +1,093,416 | 新進 | 歷史 |
| GILDGilead Sciences, Inc. | Stock | 382,362 | $3,098 萬 | 7.5% | −240,761−38.6% | 減碼 | 歷史 |
| BIIBBiogen Inc. | COM | 102,234 | $2,646 萬 | 6.4% | −2,052−2.0% | 減碼 | 歷史 |
| INCYIncyte Corp | COM | 398,699 | $2,503 萬 | 6.1% | −33,846−7.8% | 減碼 | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 374,687 | $1,923 萬 | 4.7% | −297,093−44.2% | 減碼 | 歷史 |
| GEHCGE HealthCare Technologies Inc. | Stock | 247,531 | $1,914 萬 | 4.6% | +17,942+7.8% | 加碼 | 歷史 |
| CVSCVS Health Corp | Stock | 219,000 | $1,729 萬 | 4.2% | +219,000 | 新進 | 歷史 |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 141,218 | $1,719 萬 | 4.2% | −17,851−11.2% | 減碼 | 歷史 |
| CAHCardinal Health Inc | Stock | 164,305 | $1,656 萬 | 4.0% | −99,831−37.8% | 減碼 | 歷史 |
| CNCCentene Corp | Stock | 216,416 | $1,606 萬 | 3.9% | −6,732−3.0% | 減碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 193,279 | $1,461 萬 | 3.5% | +35,304+22.3% | 加碼 | 歷史 |
| EWEdwards Lifesciences Corp | Stock | 187,556 | $1,430 萬 | 3.5% | −25,439−11.9% | 減碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 27,807 | $1,311 萬 | 3.2% | −13,340−32.4% | 減碼 | 歷史 |
| BAXBaxter International Inc | Stock | 328,132 | $1,269 萬 | 3.1% | +134,889+69.8% | 加碼 | 歷史 |
| GMEDGlobus Medical Inc | Stock | 234,374 | $1,249 萬 | 3.0% | +12,547+5.7% | 加碼 | 歷史 |
| LHLabcorp Holdings Inc. | COM NEW | 50,686 | $1,152 萬 | 2.8% | −14,171−21.8% | 減碼 | 歷史 |
| BRKRBruker Corp | COM | 127,312 | $935.5 萬 | 2.3% | +23,957+23.2% | 加碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 86,247 | $831.6 萬 | 2.0% | −9,801−10.2% | 減碼 | 歷史 |
| QGENQiagen N.V. | SHS NEW | 190,539 | $827.5 萬 | 2.0% | +89,826+89.2% | 加碼 | 歷史 |
| BIOBio-Rad Laboratories, Inc. | CL A | 23,609 | $762.3 萬 | 1.8% | +23,609 | 新進 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 145,012 | $733.6 萬 | 1.8% | −20,604−12.4% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 32,092 | $614.3 萬 | 1.5% | −20,876−39.4% | 減碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 188,111 | $589.0 萬 | 1.4% | +8,326+4.6% | 加碼 | 歷史 |
| ILMNIllumina, Inc. | COM | 40,592 | $565.2 萬 | 1.4% | +40,592 | 新進 | 歷史 |
| ALKSAlkermes plc. | SHS | 200,000 | $554.8 萬 | 1.3% | +200,000 | 新進 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 102,490 | $490.1 萬 | 1.2% | −12,676−11.0% | 減碼 | 歷史 |
| ABTAbbott Laboratories | Stock | 39,876 | $438.9 萬 | 1.1% | +39,876 | 新進 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 52,316 | $324.4 萬 | 0.8% | +1,354+2.7% | 加碼 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 148,538 | $149.4 萬 | 0.4% | 00.0% | 不變 | 歷史 |
2023 年第 3 季之後清倉（4 檔）
2023 年第 3 季季末還持有、這份申報已經沒有的部位。